Attached files

file filename
EX-99.1 - PRESS RELEASE - Orthofix Medical Inc.dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 27, 2010

 

 

Orthofix International N.V.

(Exact name of Registrant as specified in its charter)

 

 

 

Curaçao   0-19961   N/A

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

7 Abraham de Veerstraat

Curaçao

  N/A
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: 011-59-99-465-8525

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 2.02. Results of Operations and Financial Conditions

On October 27, 2010, Orthofix International N.V. (the “Company”) issued a press release (the “press release”) announcing, among other things, its results for the third quarter ended September 30, 2010. A copy of the press release is furnished herewith as Exhibit 99.1 and attached hereto.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits

 

99.1 Press release of Orthofix International N.V. dated October 27, 2010


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Orthofix International N.V.

By:

 

/s/    ROBERT S. VATERS        

 

Robert S. Vaters

Executive Vice President and Chief

Financial Officer

Date: October 27, 2010


 

EXHIBIT INDEX

 

Exhibit
No.

  

Description

    
99.1    Press release, dated October 27, 2010